MAPT and Alzheimer disease: Thus, this microglial pro-inflammatory activation may aggravate AD pathogenesis via decreased Aβ phagocytosis, increased tau seeding, loss of synaptic function, and cytokine-induced neuron death in these brain regions (Cao S. et al., 2019).